Document Detail


Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation.
MedLine Citation:
PMID:  10543676     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report a 46,XY infant with an M807T mutation in his androgen receptor that abrogated cellular responses to testosterone, but not to dihydrotestosterone (DHT), resulting in ambiguous genitalia. Treatment with a topical DHT gel restored male genital development allowing the infant to be reared in accordance with his chromosomal sex.
Authors:
Y C Ong; H B Wong; G Adaikan; E L Yong
Related Documents :
24370176 - Effect of preterm birth on motor development, behavior, and school performance of schoo...
2802526 - A model for the study of sex-linked influences through the study of different classes o...
12957476 - Peripartum sex steroid changes and maternal style in rhesus and japanese macaques.
16890246 - Early renal structure alteration in rat offspring from dams fed low protein diet.
21052006 - Residential proximity to major roads and preterm births.
11711746 - Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination.
Publication Detail:
Type:  Case Reports; Letter    
Journal Detail:
Title:  Lancet     Volume:  354     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1999 Oct 
Date Detail:
Created Date:  1999-11-10     Completed Date:  1999-11-10     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1444-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Androgen-Insensitivity Syndrome / diagnosis,  drug therapy*,  genetics
Dihydrotestosterone / therapeutic use*
Drug Monitoring / methods*
Gonadal Steroid Hormones / therapeutic use*
Humans
Infant, Newborn
Male
Receptors, Androgen / drug effects
Transcriptional Activation / drug effects
Chemical
Reg. No./Substance:
0/Gonadal Steroid Hormones; 0/Receptors, Androgen; 521-18-6/Dihydrotestosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of sleep debt on metabolic and endocrine function.
Next Document:  Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and popula...